{"anticipatedPostingDate":"2027-06","denomUnitsSelected":"Participants","description":"Participants receiving concomitant medications will be adequately monitored by ECG controls, drug concentration (where applicable), and serum electrolytes (i.e., potassium and magnesium).","reportingStatus":"NOT_POSTED","timeFrame":"Up to approximately 52 months","title":"Percentage of Participants Using Concomitant Medications","type":"SECONDARY"}